B+L secures agreement for 3D surgical navigation technology

May 3, 2014

Bausch + Lomb has entered into an exclusive license agreement for a 3-dimensional (3D) surgical navigation technology-the Cirle Surgical Navigation System-from Cirle, Inc., a medical technology incubator based in Miami, FL.

 

Bridgewater, NJ-Bausch + Lomb has entered into an exclusive license agreement for a 3-dimensional (3D) surgical navigation technology-the Cirle Surgical Navigation System-from Cirle, Inc., a medical technology incubator based in Miami, FL.

Bausch + Lomb has agreed to license the system from Cirle to pursue commercialization for cataract surgery.

“Bausch + Lomb is immensely proud to have an opportunity to partner with Cirle on the commercialization of this exciting technology,” said Cal Roberts, MD, chief medical officer, Bausch + Lomb. “The (technology) will be an important addition to ophthalmic operating rooms, which we believe will help us obtain a leading position in this market category.”

Bausch + Lomb announced its partnership with Cirle in late 2012.

“It’s very exciting to see how rapidly this technology has reached this stage of development, a testament to the productivity of industry-incubator collaborations like the unique partnership we have with Bausch + Lomb today,” said Richard Awdeh, MD, found and chief executive officer of Cirle.

 

The surgical navigation technology is not currently commercially available in the United States.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.